Association of metabolic dysfunction-associated fatty liver disease with kidney disease
TY Wang, RF Wang, ZY Bu, G Targher… - Nature Reviews …, 2022 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of fat in more
than 5% of hepatocytes in the absence of excessive alcohol consumption and other …
than 5% of hepatocytes in the absence of excessive alcohol consumption and other …
Metabolic-associated fatty liver disease: A selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
M Habibullah, K Jemmieh, A Ouda, MZ Haider… - Frontiers in …, 2024 - frontiersin.org
Background Metabolic associated fatty liver disease (MAFLD) is a novel terminology
introduced in 2020 to provide a more accurate description of fatty liver disease associated …
introduced in 2020 to provide a more accurate description of fatty liver disease associated …
[HTML][HTML] Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver
E Kaya, Y Yilmaz - Journal of clinical and translational hepatology, 2022 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
[HTML][HTML] MAFLD: How is it different from NAFLD?
C Gofton, Y Upendran, MH Zheng… - Clinical and molecular …, 2023 - ncbi.nlm.nih.gov
Abstract “Metabolic dysfunction-associated fatty liver disease (MAFLD)” is the term
suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation …
suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation …
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
M Tanaka, K Mori, S Takahashi… - Nephrology Dialysis …, 2023 - academic.oup.com
Background Possible associations of chronic kidney disease (CKD) with fatty liver (FL) and
nonalcoholic fatty liver disease (NAFLD) have recently been focused on. Metabolic …
nonalcoholic fatty liver disease (NAFLD) have recently been focused on. Metabolic …
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
G Targher, CD Byrne - Nature Reviews Nephrology, 2017 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is caused by an accumulation of fat in the liver; the
condition can progress over time to increase the risk of developing cirrhosis, end-stage liver …
condition can progress over time to increase the risk of developing cirrhosis, end-stage liver …
MAFLD and CKD: an updated narrative review
A Mantovani, R Lombardi, F Cattazzo, C Zusi… - International Journal of …, 2022 - mdpi.com
Accumulating evidence now indicates that non-alcoholic fatty liver disease (NAFLD), which
is the most common chronic liver disease observed in clinical practice worldwide, is …
is the most common chronic liver disease observed in clinical practice worldwide, is …
[HTML][HTML] An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
DQ Sun, G Targher, CD Byrne… - … surgery and nutrition, 2023 - ncbi.nlm.nih.gov
Background With the rising global prevalence of fatty liver disease related to metabolic
dysfunction, the association of this common liver condition with chronic kidney disease …
dysfunction, the association of this common liver condition with chronic kidney disease …
MAFLD and risk of CKD
DQ Sun, Y Jin, TY Wang, KI Zheng, RS Rios, HY Zhang… - Metabolism, 2021 - Elsevier
Background/aims Whereas nonalcoholic fatty liver disease (NAFLD) is a multisystem
disease, the association between metabolic dysfunction-associated fatty liver disease …
disease, the association between metabolic dysfunction-associated fatty liver disease …
NAFLD as a driver of chronic kidney disease
CD Byrne, G Targher - Journal of hepatology, 2020 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide
public health problems, affecting up to 25–30%(NAFLD), and up to 10–15%(CKD) of the …
public health problems, affecting up to 25–30%(NAFLD), and up to 10–15%(CKD) of the …